Iovance Biotherapeutics IOVA

Iovance Biotherapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$9.56-35.45%close on Oct. 29, 2026 · volume 58.5M · Yahoo Finance

Price, last 48 sessions

$10.00$12.00$14.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 29, 2026 · high $14.86 · low $8.01 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 17 →
  • 8-KOct. 29, 2026, 5 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedIovance Biotherapeutics Reports Updated IOV-LUN-202 Non-Squamous mNSCLC Data: 24.6% ORR in 69 Patients, Biomarker-Enriched Subgroup at 59.1% ORR

  • 8-KOct. 5, 2026, 5 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 4Oct. 2, 2026, 5:01 p.m. ETView on SEC.gov
  • 8-KSept. 29, 2026, 7:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 4Sept. 10, 2026, 5:01 p.m. ETView on SEC.gov
  • 4Sept. 10, 2026, 5 p.m. ETView on SEC.gov
  • 4Sept. 10, 2026, 5 p.m. ETView on SEC.gov
  • 4Sept. 3, 2026, 5:02 p.m. ETView on SEC.gov